WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

List of DDDs for 3 years revision

The DDDs, which will be reviewed at the March 2020 meeting (3 year revision) are listed below.  See also Guidelines: Part III; D Principles for reviewing and changing DDD and Part V; D Requests for changes to DDDs. The deadline for applications for alterations and comments is 1 February 2020.  

 

ATC codeATC level name (INN/generic name)DDDUnitAdm.route
A02BX14rebamipide0.3gO
A05AA04obeticholic acid10mgO
A06AX07plecanatide3mgO
A10BF03voglibose0.6mgO
A10BH07evogliptin5mgO
A16AX14migalastat61.5mgO
B01AC26vorapaxar2.08mgO
B01AC27selexipag1.8mgO
B03AB09ferric proteinsuccinylate80mgO Fe3+
C09CA10fimasartan60mgO
H05BX04etelcalcetide2.1mgP
J01DD52ceftazidime and beta-lactamase inhibitor6gP
J05AF13tenofovir alafenamide25mgO
L03AA17pegteograstim0.3mgP
L04AC13ixekizumab2.9mgP
L04AX03methotrexate2.5mgP
N04BX04opicapone50mgO
N05AX16brexpiprazole3mgO
N07BC05levomethadone15mgO
N07XX11pitolisant18mgO
R06AA09doxylamine25mgO
R06AE03cyclizine0.1gP

Last updated: 2019-12-12